According to Dr. Reddy's's latest financial reports the company's total assets are $4.47 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | $3.92 B | 1.52% |
2022-03-31 | $3.86 B | 6.83% |
2021-03-31 | $3.61 B | 17.36% |
2020-03-31 | $3.08 B | -5.13% |
2019-03-31 | $3.24 B | -6.3% |
2018-03-31 | $3.46 B | 2.13% |
2017-03-31 | $3.39 B | 8.44% |
2016-03-31 | $3.12 B | 0.42% |
2015-03-31 | $3.11 B | 9.53% |
2014-03-31 | $2.84 B | 8.45% |
2013-03-31 | $2.62 B | 11.67% |
2012-03-31 | $2.34 B | 10.29% |
2011-03-31 | $2.12 B | 18.77% |
2010-03-31 | $1.79 B | 8.67% |
2009-03-31 | $1.64 B | -23.14% |
2008-03-31 | $2.14 B | 7.62% |
2007-03-31 | $1.99 B | 28.83% |
2006-03-31 | $1.54 B | 130.55% |
2005-03-31 | $0.67 B | 9.09% |
2004-03-31 | $0.61 B | 122.96% |
2003-03-31 | $0.27 B | 21.53% |
2002-03-31 | $0.22 B | 60.02% |
2001-03-31 | $0.14 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Novartis NVS | $99.94 B | 2,131.58% | ๐จ๐ญ Switzerland |
Pfizer PFE | $226.50 B | 4,957.34% | ๐บ๐ธ USA |
Sanofi SNY | $139.81 B | 3,021.83% | ๐ซ๐ท France |
GlaxoSmithKline GSK | $75.11 B | 1,577.14% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $43.47 B | 870.80% | ๐ฎ๐ฑ Israel |